Oracle Health
OperatingORACLE HEALTH, INC.
Biotech · Safety Harbor, FL · Founded 2019
Tiny implantable cardiac device using telemedicine and AI
Financials
FY2017–FY2025 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
13 people
Show 4 more peopleShow fewer
Electrophysiology Cardiologist from Ohio State University. Expertise in managing cardiac arrhythmia and cardiac ablations.
Lauren serves as a Board Member for Future Cardia. Lauren is an entrepreneur and senior executive with over 25 years of experience delivering results. She is currently the CEO of Meel Corp., a producer and distributor of frozen foods to the retail, club and food service channels. Prior to Meel Corp., Lauren was the co-founder of Investran, the Private Equity industry’s leading platform for fund administration and investor reporting. She was also part of the founding team of TM1 which, through a series of M&A transactions, is now the centerpiece of IBM’s Planning and Analytics platform. Lauren is a seed investor in investment technology platforms and serves as a strategic advisor and board member to several of them.
Names and titles as disclosed on SEC Form 1-A, SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 6 of 7 annual reports (FY2019–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 74 filings on EDGAR- Form QUALIFJun 9, 20269999999994-26-000118EDGAR
- Form 1-A POSJun 2, 20260001213900-26-063644EDGAR
- Form 1-KApr 30, 20260001213900-26-049829EDGAR
- Form C-ARApr 30, 20260001213900-26-049838EDGAR
- Form 1-SASep 29, 20250001213900-25-093039EDGAR
- Form 253G2Jun 24, 20250001213900-25-057236EDGAR
- Form QUALIFJun 23, 20259999999994-25-000114EDGAR
- Form C-UJun 23, 20250001665160-25-001229EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.